TickerFacts.

Matinas BioPharma Holdings, Inc. (MTNB): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$15.50M
Year ended 2023-12-31
2013-12-31: -$3.08M2014-12-31: -$8.25M2015-12-31: -$7.89M2016-12-31: -$6.12M2017-12-31: -$12.40M2018-12-31: -$10.86M2019-12-31: -$14.50M2020-12-31: -$17.37M2021-12-31: -$15.48M2022-12-31: -$20.05M2023-12-31: -$15.50M-$15.50M
2013-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$15.50Mn/m2025-04-15, From 2023-01-01
2022-12-31-$20.05Mn/m2024-03-27, From 2022-01-01
2021-12-31-$15.48Mn/m2023-03-15, From 2021-01-01
2020-12-31-$17.37Mn/m2022-03-11, From 2020-01-01
2019-12-31-$14.50Mn/m2021-03-29, From 2019-01-01
2018-12-31-$10.86Mn/m2020-03-09, From 2018-01-01
2017-12-31-$12.40Mn/m2019-04-01, From 2017-01-01
2016-12-31-$6.12Mn/m2018-03-16, From 2016-01-01
2015-12-31-$7.89Mn/m2018-03-16, From 2015-01-01
2014-12-31-$8.25Mn/m2016-03-30, From 2014-01-01
2013-12-31-$3.08Mn/a2015-03-31, From 2013-01-01